Investing Profile

Genghis Lloyd-Harris

InvestorVC

Partner at Abingworth

abingworth.com/team/genghis-l...London

‌

‌

‌

Your Intro Paths to Genghis Lloyd-Harris

‌

‌

‌

‌

‌

‌

‌

‌

‌

‌

‌

‌

Find Genghis Lloyd-Harris on

cb

Current Investing Position

Abingworth Partner

Investment Range

$15.0M - $30.0M

Sweet Spot

$22.5M

Investments On Record

9

Current Fund Size

$465M

Genghis Lloyd-Harris is on these Sector & Stage Rankings

BioTech (Series B)Medical Devices (Series B)Medical Devices (Series A)Pharmaceuticals (Series B)Pharmaceuticals (Series A)BioTech (Series A)Health & Hospital Services (Series B)Health IT (Series A)Health & Hospital Services (Series A)London Diagnostics (Series B)Diagnostics (Series A)Health IT (Series B)

Genghis Lloyd-Harris's Investments On Record (5)

Company	StageDateRound Size	Total Raised
Nouscom	Series BNov 2017$49M	$140M
Co-investors: Scott Rocklage (5am Ventures), Guido Magni (Versant Ventures), Hakan Goker (M Ventures (Merck)), Sofia Ioannidou (Andera Partners), Joachim Rothe (EQT Life Sciences)
GenSight Biologics	Series BJul 2015$36M Series AApr 2013$42M	$130M
Co-investors: Cedric Moreau (Soffinova Partners), Guido Magni (Versant Ventures)
Wilson Therapeutics	Series BApr 2014$40M	$40M
Co-investors: Marten Steen (HealthCap), Bali Muralidhar (Abingworth)
Syntaxin	Series CNov 2010$29M Series BOct 2007$32M Series ANov 2005$10M	$71M
Co-investors: Deborah Harland (SR One), René Kuijten (EQT Life Sciences)
Synosia Therapeutics	Series BJan 2009$29M Series UnknownJan 2007$33M	$92M
Co-investors: Heath Lukatch (Red Tree Venture Capital)

Investors who invest with Genghis Lloyd-Harris

Andrew Sinclair

Brian Gallagher

Jacqueline Grant